← Back to contracts

Let-7b in BPD

US · IL National Heart Lung and Blood Institute grant open #nih-5R01HL156275-03

Summary

This project investigates microRNA let-7b-5p as a robust biomarker for bronchopulmonary dysplasia (BPD) in extremely low birth weight infants and its role in lung development and angiogenesis.

What they want

The project will test central hypotheses that let-7b-5p is a valuable biomarker for BPD staging, progression, and therapy response; is released from airway epithelial cells by oxidative stress; contributes to dysregulated angiogenesis in BPD; and that its inhibition improves lung angiogenesis and attenuates the BPD phenotype. This will be achieved through three specific aims: 1) measuring plasma let-7b-5p in serial samples from 150 extremely preterm infants to track lung disease progression and therapy response, 2) determining mechanisms of let-7b release by newborn mouse lung airway epithelium using novel transgenic mice and cell culture models, and 3) determining effects of excessive let-7b-5p signaling on lung microvascular development using newborn mouse models.
Deliverables
  • Defined temporal changes in let-7b-5p with respiratory illness severity, BPD staging, lung mechanics, and clinical therapies
  • Confirmation of oxidative stress as a key upstream mechanism for let-7b-5p release
  • Determination of the role of Nrf2 and NF-kB signaling in let-7b-5p release
  • Determination of effects of excessive let-7b-5p signaling on lung microvascular development
  • Evidence that inhibition of let-7b-5p improves lung development in hyperoxia-exposed newborn mouse lung
Technical requirements
  • Measurement of let-7b-5p in serial plasma samples
  • Use of a well-characterized prospective cohort of 150 extremely preterm infants
  • Use of novel transgenic mice
  • Testing the hypothesis that reduction of mitochondrial ROS reduces let-7b-5p and the BPD phenotype
  • Determination of the role of Nrf2 and NF-kB signaling using specific inhibitors/modulators in cell culture models
  • Over-expression of let-7b-5p to induce impaired lung microvascular development in newborn mice
  • Inhibition of let-7b-5p in hyperoxia-exposed newborn mouse lung (BPD model)
Let-7b in BPD
Onboard